Michał Biśta

3.5k total citations · 1 hit paper
20 papers, 2.5k citations indexed

About

Michał Biśta is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Michał Biśta has authored 20 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Michał Biśta's work include Chemical Synthesis and Analysis (5 papers), Cancer-related Molecular Pathways (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Michał Biśta is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Cancer-related Molecular Pathways (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Michał Biśta collaborates with scholars based in United States, Germany and United Kingdom. Michał Biśta's co-authors include Tad A. Holak, Michael Sixt, Dieter E. Jenne, Dorothee Neukirchen, Zena Werb, Frank Bradke, Álvaro H. Crevenna, Roland Wedlich‐Söldner, Julia Riedl and Kai Kessenbrock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Michał Biśta

20 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifeact: a versatile marker to visualize F-actin

2008 1.7k citations Julia Riedl, Álvaro H. Crevenna et al. Nature Methods profile →

Peers

Countries citing papers authored by Michał Biśta

Since Specialization

Citations

This map shows the geographic impact of Michał Biśta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Biśta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Biśta more than expected).

Fields of papers citing papers by Michał Biśta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Biśta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Biśta. The network helps show where Michał Biśta may publish in the future.

Co-authorship network of co-authors of Michał Biśta

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Biśta. A scholar is included among the top collaborators of Michał Biśta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Biśta. Michał Biśta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs	Nature Communications	Matthew A. Coelho, Étienne De Braekeleer et al.	58
2	Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1	Acta Crystallographica Section D Structural Biology	Jakub Lupták, Michał Biśta et al.	7
3	Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1	SLAS DISCOVERY	Joseph Shaw, Ian L. Dale et al.	31
4	Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease	Nature Communications	Michał Biśta, Matthew D. Newton et al.	54
5	Quantifying the relationship between inhibition of VEGF receptor 2, drug‐induced blood pressure elevation and hypertension	British Journal of Pharmacology	Michał Biśta, Matthew Skinner et al.	16
6	MTH1 Substrate Recognition—An Example of Specific Promiscuity	PLoS ONE	J. Willem M. Nissink, Michał Biśta et al.	19
7	Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival	Journal of Medicinal Chemistry	Jason G. Kettle, Michał Biśta et al.	100
8	Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction	Structure	Michał Biśta, Siglinde Wolf et al.	47
9	MDMX contains an autoinhibitory sequence element	Proceedings of the National Academy of Sciences	Michał Biśta, Miriana Petrovich et al.	45
10	Domain–domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy	Proceedings of the National Academy of Sciences	Michał Biśta, Stefan M.V. Freund et al.	34
11	Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists	PLoS ONE	David Ryan Koes, Kareem Khoury et al.	79
12	On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53	PLoS ONE	Michał Biśta, David C. Smithson et al.	46
13	1,4‐Thienodiazepine‐2,5‐diones via MCR (I): Synthesis, Virtual Space and p53‐Mdm2 Activity	Chemical Biology & Drug Design	Yijun Huang, Siglinde Wolf et al.	50
14	Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists	Angewandte Chemie International Edition	Anna Czarna, Barbara Beck et al.	113
15	Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists	Angewandte Chemie	Anna Czarna, Barbara Beck et al.	21
16	Robust NMR Screening for Lead Compounds Using Tryptophan-Containing Proteins	Journal of the American Chemical Society	Michał Biśta, Alexander Dömlingꝉ et al.	26
17	Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus	Biochemical Journal	Katarzyna Pustelny, Michał Biśta et al.	36
18	Enzymatic Activity of the Staphylococcus aureus SplB Serine Protease is Induced by Substrates Containing the Sequence Trp-Glu-Leu-Gln	Journal of Molecular Biology	Grzegorz Dubin, Katarzyna Pustelny et al.	39
19	Lifeact: a versatile marker to visualize F-actin breakdown →	Nature Methods	Julia Riedl, Álvaro H. Crevenna et al.	1702
20	A novel member of the thermolysin family, cloning and biochemical characterization of metalloprotease from Staphylococcus pseudintermedius.	Acta Biochimica Polonica	Benedykt Władyka, Michał Biśta et al.	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact